LDS/Medical Tests/Biopsy, Pancreas

Biopsy, Pancreas

Biopsy is indicated in the clinical management of various pathologies of the pancreas. The most commonly performed procedure is endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA). However, in recent years, endoscopic ultrasound-guided trucut biopsy (EUS-TCB) is gaining popularity in complementing EUS-FNA. Percutaneous biopsy may be indicated in some cases and it can be performed under either ultrasound guidance or CT-guidance. Surgical biopsy can also be performed using minimally invasive laparoscopy.

Pancreatic biopsy is feasible in the outpatient setting, although, a short hospital stay may be indicated depending on the presence of any co-morbidities. All approaches to the biopsy procedure are safe and generally highly effective when applied in an appropriate clinical context. Contraindications for the procedure include the presence of intervening anatomic structures and uncorrected coagulopathy. Complications are rare when performed by a skilled physician and include pain/discomfort at the site of biopsy, hematoma/hemorrhage and infection at the biopsy site.

  • Diagnosis and management of pancreatic neoplasms
  • Management of other focal pancreatic lesions – focal pancreatitis, tuberculosis, lymphoma, cysts and suspected metastasis
Interpretation of the biopsy of the pancreas is dependent on the clinical presentation and pathologic findings. Clinical and radiologic data are important in the interpretation of the biopsy findings.

There are no universal reference ranges for pancreas biopsy specimens. In general, normal pancreas tissue consists of benign exocrine pancreatic glands and ducts; and endocrine pancreatic glands all embedded in a fibrovascular connective tissue stroma.

The biopsy specimen is formalin fixed and embedded in paraffin. Sections are stained with hematoxylin and eosin, and various immunohistochemical stains at the discretion of the pathologist. Cytology specimens are processed in the lab according to their respective manufacturer’s guidelines. Cytospin smears are stained with Pap stain, Diff-Quik/ Romanowsky and H&E stains. If there is enough specimen, a cell block is prepared which allows immunohistochemistry to be performed.

Biopsies and cytology samples are obtained by an interventional radiologist (PTCA) or a gastroenterologist (ERCP). Biopsy specimens are placed directly in formalin fixative. Cytology samples need to be placed in fixative solutions provided by the laboratory and vary depending on the commercial platforms used by the laboratory. Rarely, culture is indicated and tissue for culture should be sent in a sterile container to the laboratory for microbiological assessment.

Serum biochemistry – liver function tests and pancreatic enzymes (amylase and/or lipase). Serum biochemistry for cancer biomarkers such as CA19-9, CEA and other hormones secreted by neuroendocrine tumors (insulin, gastrin, glucagon, somatostatin, etc.) which varies from case to case.
Usually 24 hours for routine light microscopy, longer for immunohistochemical stains, which varies from case to case.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login